Product Information
MATZIM LA 180 MG TABLET is a generic product labeled by Actavis Pharma, Inc., priced at $1.0508 per EA under NDC 52544069119. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
180 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
52544069119
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
DILTIAZEM HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077686On Market Since
3/28/2011
Pharmacological Classes
Price Statistics
The NADAC for MATZIM LA 180 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 53.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.0508 per EA |
|---|---|
| All-time high | $2.3015 (Oct 15, 2014) |
| All-time low | $1.0231 (Nov 20, 2024) |
| 52-week high | $1.7239 |
| 52-week low | $1.0508 |
| Median price | $2.0957 |
| Average price | $1.9832 |
| Largest weekly change | +47.4% (Aug 21, 2024) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 9 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 9 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 89% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MATZIM LA 180 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MATZIM LA 180 MG TABLET, manufactured by Actavis Pharma, Inc., is $1.0508 per EA (NDC 52544069119), effective Jun 24, 2026.
How has the price of MATZIM LA 180 MG TABLET changed over time?
Over the history we have for it, the NADAC for MATZIM LA 180 MG TABLET has declined 53.5%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MATZIM LA 180 MG TABLET?
Since Nov 28, 2013, the NADAC for MATZIM LA 180 MG TABLET has ranged from a low of $1.0231 (Nov 20, 2024) to a high of $2.3015 (Oct 15, 2014), with a median of $2.0957 per EA.
Are there cheaper alternatives to MATZIM LA 180 MG TABLET?
Yes. 9 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, DILTIAZEM 24HR ER 180 MG CAP, is $0.1160 per EA — about 89% below MATZIM LA 180 MG TABLET.
Who manufactures MATZIM LA 180 MG TABLET?
MATZIM LA 180 MG TABLET (NDC 52544069119) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification